Oliver Lagore Vanvalin Investment Group Neogenomics Inc Transaction History
Oliver Lagore Vanvalin Investment Group
- $337 Million
- Q2 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Neogenomics Inc stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 400 shares of NEO stock, worth $5,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$5,856
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$288 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$207 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$128 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$98.5 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$96.9 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.84B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...